CG
The Carlyle Group Inc.
CG's fundamentals are weak and it looks expensive: trading at 42x earnings, about three times its usual 15x. Analysts expect earnings growth, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CG Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| N/A | |
| N/A |
CG's profitability is currently stable, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like CG.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.4x | $5.99 | -85% |
| Forward | 9.5x | $39.36 | — |
| Fair | 14x | $13.43 | -66% |
| Expensive | 36x | $33.42 | -15% |
| Current | 42x | $39.36 | — |
Historical ranges are pointers, not guarantees.
CG's PE is in its expensive range at 42x. If earnings grow as analysts expect, today's price would be 9.5x next year's earnings, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CG, with profitability holding steady. However, they disagree widely on these estimates.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.16 | +343% |
| Q3 2026 | $0.94 | -47% |
| Q2 2026 | $0.96 | -72% |
| Q1 2026 | $1.46 | -50% |
| Q4 2025 | $2.18 | -21% |
| Q3 2025 | $1.78 | +493% |
| Q2 2025 | $3.41 | +$4.52 |
| Q1 2025 | $2.94 | +$4.72 |
| Q4 2024 | $2.77 | +$4.45 |
CG has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $334.1M | +0.4% |
| Q2 2026 | $1.1B | -29% |
| Q1 2026 | $254M | -74% |
| Q4 2025 | $1.9B | +84% |
| Q3 2025 | $332.7M | -87% |
| Q2 2025 | $1.6B | +47% |
| Q1 2025 | $973.1M | +41% |
| Q4 2024 | $1B | +11% |
CG's revenue has slid since its 2021 peak: $334M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -16% | -5 points |
| Q2 2026 | 22% | -3 points |
| Q1 2026 | -45% | -62 points |
| Q4 2025 | 27% | +4.9 points |
| Q3 2025 | -11% | -41 points |
| Q2 2025 | 25% | +4.1 points |
| Q1 2025 | 17% | -1.6 points |
| Q4 2024 | 22% | +113 points |
CG has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over CG on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $333.7M | +$1.9B |
| Q2 2026 | -$32.5M | +$153.8M |
| Q1 2026 | -$1.3B | -$901.7M |
| Q4 2025 | -$1.2B | -$857.6M |
| Q3 2025 | -$1.6B | -305% |
| Q2 2025 | -$186.3M | +$1.1B |
| Q1 2025 | -$368.8M | -748% |
| Q4 2024 | -$379.5M | -260% |
CG's free cash flow was −$2.2B over the past year, against −$2.5B the year before. Free cash flow isn't a meaningful measure for financial services companies like CG.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.5% | -13M shares |
| 1 year | -5.9% | -22.2M shares |
| 3 years | -2.6% | -9.4M shares |
| 5 years | -2.9% | -10.4M shares |
| Available history | -0.8% | -3M shares |
CG has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $210.4M |
| Q2 2026 | $304.1M |
| Q1 2026 | $204.8M |
| Q4 2025 | $203.7M |
| Q3 2025 | $202.7M |
| Q2 2025 | $103.6M |
| Q1 2025 | $176.5M |
| Q4 2024 | $75.8M |
CG spent $923M buying back its own shares over the past year, up 65% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.0x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -1.8x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
CG has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CG.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.1 | Neutral |
| Stochastic | 26.1 | Neutral |
CG's weekly RSI is 39 (neutral) and its Stochastic is 26 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CG PE vs Financial Services Sector
| Metric | CG | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 13x | 222% above |
| PE % | 87 | 63 | 24 pts above |
CG is trading at 42x earnings, a 222% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.1 | 0.8% above |
| 20 week MA | $43.1 | 8.7% below |
| 50 week MA | $48.5 | 19% below |
| 100 week MA | $50.5 | 22% below |
| 200 week MA | $44.4 | 11% below |
CG has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 11% below its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.2 | $31.4 | +0.4% |
| 2021 | $31.4 | $55.5 | +77% |
| 2022 | $55.5 | $29.9 | -46% |
| 2023 | $29.9 | $40.7 | +36% |
| 2024 | $40.7 | $50.9 | +25% |
| 2025 | $50.9 | $61.1 | +20% |
| 2026 YTD | $61.1 | $39.4 | -36% |
CG has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.